ORENITRAM
Live / Registered — Registered and renewed (as of 10 Aug 2024)
What this means for you
Registered since 10 Jun 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Jun 2024).
Record
- Serial number
- 85755001
- Registration number
- 4548443
- Mark type
- Stylized text
- Filed
- 16 Oct 2012
- Published for opposition
- 26 Mar 2013
- Registered
- 10 Jun 2014
- Next maintenance due
- 10 Jun 2024
- Attorney of record
- Norm J. Rich
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations used in the treatment of cardiovascular, cardiopulmonary, pulmonary, and vascular diseases; pharmaceutical preparations for the treatment of pulmonary hypertension
Owner
- United Therapeutics Corporation, Silver Spring, MD, US
- United Therapeutics Corporation, Silver Spring, MD, US
- United Therapeutics Corporation, Silver Spring, MD, US
Prosecution history
- 10 Aug 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 10 Aug 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 10 Aug 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 10 Aug 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 May 2024 — TEAS SECTION 8 & 9 RECEIVED
- 10 Jun 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 21 Aug 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 21 Aug 2020 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 21 Aug 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Jun 2020 — TEAS SECTION 8 & 15 RECEIVED
- 10 Jun 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Jun 2014 — REGISTERED-PRINCIPAL REGISTER
- 03 May 2014 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Apr 2014 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 29 Apr 2014 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED